DOCSLIB.ORG

Dow Jones Quiz

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Dow Jones Quiz Name ________________________________ Date ________ DOW JONES POP QUIZ DIRECTIONS: Try to identify the following companies that are in the Dow Jones Industrial Average. 1. _____________ I'm a major telecommunications giant, and one of my initials stands for telegraph. 2. _____________ I was founded in 1837. Some of my 250 plus brands are Tide, Crest, Folgers, Mr. Clean, Cover Girl, Ivory, Pepto-Bismol, Pantene, Pampers and Bounty. 3. _____________ I've made and sold everything from light bulbs to dishwashers to aircraft engines. I even bought NBC. 4. _____________ I've made a lot of money since 1923 with a couple of mice, a few ducks and now ABCbroadcasting. 5. _____________ I was founded in 1886. Some of my best-known brands include Band-Aids, Tylenol, Motrin, Neutrogena, Mylanta, Reach and Acuvue. 6. _____________ Founded in Arkansas, I employed more than a million people in more than four thousand superstores around the world. 7. _____________ My spokesman is a big clown. 8. _____________ I am the world’s second largest food company with annual revenues of $54.4 billion. If you have ever eaten Oreo’s, Chips Ahoy, or Jell-O; had a drink of Tang, Kool-Aid, or Capri Sun; or chewed a stick of Dentyne, Trident, or Stride gum; you know my products very well. 9. _____________ Don't leave home without me. 10. _____________ Based in Atlanta, I sell 3 trillion ounces of beverages each year and plan to increase that number. 11. _____________ Known mostly for my software, I'm one of the most valuable companies on earth. 12. _____________ I cater do the do-it-yourself consumer. I'm the 2nd largest retailer in the U.S., third in the world and I like to sponsor Olympic teams. FinanceInTheClassroom.org DOW JONES POP QUIZ KEY 1. AT&T 2. Proctor & Gamble 3. General Electric 4. Disney 5. Johnson & Johnson 6. WalMart 7. McDonald’s 8. Kraft Foods 9. American Express 10. Coca Cola 11. Microsoft 12. Home Depot FinanceInTheClassroom.org .
Load more

Recommended publications
  • Get to the Heart of Pain Relief
    Get to the heart of pain relief Explain why analgesic choice matters to patients with, or at risk for, cardiovascular disease Counseling tips | Dosage | Savings Analgesic considerations that matter to the heart Reinforce your TYLENOL® recommendation to patients with, or at risk for, cardiovascular disease with these counseling tips: TYLENOL® won’t increase the risk of heart attack, heart failure, or stroke the way ibuprofen or naproxen sodium can1 TYLENOL® won’t interfere with aspirin heart therapy the way ibuprofen can2 TYLENOL® won’t increase blood pressure like NSAIDs sometimes can3,4 TYLENOL® won’t interfere with certain high blood pressure medications, such as diuretics and ACE inhibitors, the way NSAIDs sometimes can3,4 Order patient education, samples, and coupons at TylenolProfessional.com Not a member? Register today! The efficacy and safety of TYLENOL® at 4000 mg/day are well established. Healthcare professionals may exercise their discretion and recommend up to 4000 mg. Dosage for Adults Recommended dose from your healthcare professional: mg/day TYLENOL® Regular Strength Active ingredient: acetaminophen 325 mg (per tablet) Use only as directed. DOSE & FREQUENCY DAILY LIMIT 2 tablets every 4 to 6 hours Do not take more than 10 tablets while symptoms last in 24 hours, unless directed by your doctor TYLENOL® Extra Strength Active ingredient: acetaminophen 500 mg (per caplet) Use only as directed. DOSE & FREQUENCY DAILY LIMIT 2 caplets every 6 hours while Do not take more than 6 caplets symptoms last in 24 hours, unless directed by your doctor TYLENOL® 8 HR Arthritis Pain Active ingredient: acetaminophen 650 mg (per extended-release caplet) Use only as directed.
    [Show full text]
  • Greenberg V. Procter & Gamble
    RECOMMENDED FOR FULL-TEXT PUBLICATION Pursuant to Sixth Circuit I.O.P. 32.1(b) File Name: 13a0203p.06 UNITED STATES COURT OF APPEALS FOR THE SIXTH CIRCUIT _________________ In re: DRY MAX PAMPERS LITIGATION. X _____________________________________ - - - No. 11-4156 DANIEL GREENBERG, - > Objector-Appellant, , - ANGELA CLARK, et al., - - Plaintiffs-Appellees, - - v. - - - PROCTER & GAMBLE COMPANY; PROCTER & - GAMBLE PAPER PRODUCTS COMPANY; - PROCTER & GAMBLE DISTRIBUTING LLC, - Defendants-Appellees. - - N Appeal from the United States District Court for the Southern District of Ohio at Cincinnati. No. 1:10-cv-301—Timothy S. Black, District Judge. Argued: October 4, 2012 Decided and Filed: August 2, 2013 Before: COLE and KETHLEDGE, Circuit Judges; and THAPAR, District Judge.* _________________ COUNSEL ARGUED: Adam E. Schulman, CENTER FOR CLASS ACTION FAIRNESS LLC, Washington, D.C., for Appellant. Lynn Lincoln Sarko, KELLER ROHRBACK L.L.P., Seattle, Washington, for Plaintiffs-Appellees. D. Jeffrey Ireland, FARUKI IRELAND & COX P.L.L., Dayton, Ohio, for Defendants-Appellees. ON BRIEF: Adam E. Schulman, Theodore H. Frank, CENTER FOR CLASS ACTION FAIRNESS LLC, Washington, D.C., for Appellant. Lynn Lincoln Sarko, Gretchen Freeman Cappio, Harry Williams IV, KELLER ROHRBACK L.L.P., Seattle, Washington, for Plaintiffs- * The Honorable Amul R. Thapar, United States District Judge for the Eastern District of Kentucky, sitting by designation. 1 No. 11-4156 Greenberg v. Procter & Gamble Co., et al. Page 2 Appellees. D. Jeffrey Ireland, Brian D. Wright, FARUKI IRELAND & COX P.L.L., Dayton, Ohio, for Defendants-Appellees. KETHLEDGE, J., delivered the opinion of the court, in which THAPAR, D. J., joined. COLE, J. (pp. 15–16), delivered a separate dissenting opinion.
    [Show full text]
  • Kraft Foods Inc(Kft)
    KRAFT FOODS INC (KFT) 10-K Annual report pursuant to section 13 and 15(d) Filed on 02/28/2011 Filed Period 12/31/2010 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 (Mark one) FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2010 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER 1-16483 Kraft Foods Inc. (Exact name of registrant as specified in its charter) Virginia 52-2284372 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) Three Lakes Drive, Northfield, Illinois 60093-2753 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: 847-646-2000 Securities registered pursuant to Section 12(b) of the Act: Title of each class Name of each exchange on which registered Class A Common Stock, no par value New York Stock Exchange Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes x No ¨ Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ¨ No x Note: Checking the box above will not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Exchange Act from their obligations under those Sections.
    [Show full text]
  • Women in Business Awards Luncheon at the Hotel Irvine, Where Aston Martin Americas President Laura Schwab Delivered the Keynote Address
    10.5.20 SR_WIB.qxp_Layout 1 10/2/20 12:14 PM Page 29 WOMEN IN BUSINESS NOMINEES START ON PAGE B-60 INSIDE 2019 WINNERS GO BIG IN IRVINE, LAND NEW PARTNERS, INVESTMENTS PAGE 30 PRESENTED BY DIAMOND SPONSOR PLATINUM SPONSORS GOLD SPONSOR SILVER SPONSORS 10.5.20 SR_WIB.qxp_Layout 1 10/2/20 1:36 PM Page 30 30 ORANGE COUNTY BUSINESS JOURNAL www.ocbj.com OCTOBER 5, 2020 Winning Execs Don’t Rest on Their Laurels $1B Cancer Center Underway; Military Wins; Spanish Drug Investment Orange County’s business community last year celebrated the Business Journal’s 25th annual Women in Business Awards luncheon at the Hotel Irvine, where Aston Martin Americas President Laura Schwab delivered the keynote address. The winners, selected from 200 nominees, have not been resting on their laurels, even in the era of the coronavirus. Here are updates on what the five winners have been doing. —Peter J. Brennan Avatar Partners City of Hope Shortly after Marlo Brooke won the Busi- (AR) quality assurance solution for the U.S. As president of the City of Hope Orange employees down from Duarte. Area univer- ness Journal’s award for co-founding Hunt- Navy for aircraft wiring maintenance for the County, Annette Walker is orchestrating a sities could partner with City of Hope. ington Beach-based Avatar Partners Inc., Naval Air Systems Command’s Boeing V- $1 billion project to build one of the biggest, While the larger campus near the Orange she was accepted into the Forbes Technol- 22 Osprey aircraft. and scientifically advanced, cancer research County Great Park is being built, Walker in ogy Council, an invitation-only community Then the Air Force is using Avatar’s solu- centers in the world.
    [Show full text]
  • United States District Court for the Central District Of
    Case 2:18-cv-09655 Document 1 Filed 11/15/18 Page 1 of 38 Page ID #:1 SIMMONS HANLY CONROY LLC 1 Crystal Foley (SBN 224627) 2 [email protected] 100 N. Sepulveda Blvd., Suite 1350 3 Los Angeles, CA 90245 4 Phone: (310) 322-3555 5 Mitchel M. Breit (pro hac vice 6 forthcoming) [email protected] 7 112 Madison Avenue 8 New York, New York 10016-7416 Phone: (212) 784-6400 9 10 Attorneys for Plaintiff 11 12 UNITED STATES DISTRICT COURT FOR THE CENTRAL DISTRICT OF CALIFORNIA 13 WESTERN DIVISION 14 TOYA EDWARDS on behalf of Case No.: ____________________2:18-cv-9655 15 herself and all others similarly 16 situated, Plaintiff, CLASS ACTION COMPLAINT 17 v. 18 DEMAND FOR JURY TRIAL WALMART, INC. 19 20 Defendant. 21 CLASS ACTION COMPLAINT 22 Plaintiff Toya Edwards individually and on behalf of all others similarly 23 situated, brings this action against Defendant Walmart, Inc. (“Walmart”). The 24 following allegations are based upon personal knowledge as to Plaintiff’s own 25 conduct, the investigation of counsel, and upon information and belief as to the acts 26 of others. 27 28 1 CLASS ACTION COMPLAINT Case 2:18-cv-09655 Document 1 Filed 11/15/18 Page 2 of 38 Page ID #:2 1 INTRODUCTION 2 1. Walmart is the world’s largest retail company operating thousands of 3 retail stores worldwide. 4 2. Walmart stores sell all types of products to the American public, 5 including toys, groceries, sports and outdoor equipment, electronics, home goods, 6 school supplies, apparel, cosmetics, health and wellness products, and many more.
    [Show full text]
  • Bloomsburg Investment Group
    Bloomsburg Investment Group Equity Analysis The Procter & Gamble Company (PG) Analyst: Gerrick Hardy, Class of 2021 Trevor Luzi, Mackenzie Gross, Class of 2022 Bloomsburg Investment Group Opinion: After our group's thorough analysis, we believe it is in the best interest of the group if our holding in Procter & Gamble (PG) is partially liquidated. Although our group remains bullish about the company, we think taking some profits from PG's recent run-up and allocating funds elsewhere in the sector would be most beneficial. While the company has provided strong organic growth in each of the two previous quarters, a number of headwinds remain in the way which will likely restrict future growth. A stronger U.S. Dollar has essentially offset the organic revenue growth, and the rise in transportation costs and commodity prices has and will likely continue to squeeze the margins of PG. With consumer tastes trending towards less expensive generic brands, customers may not respond favorably to recent price increases of some of Procter & Gamble’s largest brands. Our sector believes PG is currently trading at a premium that will not be satisfied with future growth. Despite all of this, we are still bullish because of the high dividend yield that the company has increased for 62 consecutive years, wide array of brand offerings, and brand loyalty and recognition, among other factors. Considering cross-current risks that exist in the macroeconomic environment and the potential of an upcoming recession or economic downturn, Procter & Gamble will continue to provide stable growth and hedge our portfolio. Corporate Summary: Corporate Details: Name Procter & Gamble Co The Procter & Gamble Company, founded in 1837, is Ticker PG a global manufacturer and distributor of household Domicile United States goods.
    [Show full text]
  • Ariel Egypt: from Market Penetration to Fierce Competition
    205 Chapter 13 Ariel Egypt: From Market Penetration to Fierce Competition Ahmed Tolba American University in Cairo (AUC), Egypt EXECUTIVE SUMMARY This case study examines the past and present challenges facing Ariel, a long-time market leader in the detergent sector in Egypt whose market share has started to slip. In particular, it examines the market- ing strategies and performance of Ariel High Suds, which is witnessing a declining market share as well as a decline in the overall high-suds market due to fierce competition and the growing low-suds market in Egypt. INTRODUCTION “Ariel will always be the brand of the people that provides superior cleaning no matter what “Ariel ranks number one top-of-mind brand in happens in the market, thanks to 13 years of road Egypt, ahead of even Coke and Pepsi! That’s shows and events that have brought Ariel so close an incredible success story,” said Hany Farouk, to the hearts and minds of Egyptian consumers.” Ariel Egypt Brand Manager, beaming at Waleed Smiling, Azmy added: “And don’t forget that Azmy, Account Manager of Saatchi & Saatchi, Ariel was the pioneer in introducing the reality the promotional company of Procter & Gamble concept in its campaigns, and competitors are (P&G), and at Hamed Ibrahim, its General Man- just trying to replicate our ideas.” Farouk took a ager. Ibrahim nodded in satisfaction, saying: deep breath and added: “But we need to save the position of Ariel Hand Wash in the market. We DOI: 10.4018/978-1-60960-583-4.ch013 Copyright © 2011, IGI Global.
    [Show full text]
  • Directoryproduct
    FOODSERVICE PRODUCT Directory FIRST HALF 2018 Sour Patch ID | 02.22.13 | 41692 CONNECT WITH CUSTOMERS THROUGH ON-BRAND Sn & ts Brands matter to customers. Mondelezack Internationals offers a full portfolio S of sweet,w savorye and eportion-conscious snacks with the brand names they love, plus branded inclusions that help sweeten dessert sales. Keep up with evolving snacking trends and put the power of preferred brands behind you with classic snacks, new products and innovative applications. Classic Cookies & Crackers Morning Must-Haves • OREO • CHIPS AHOY! • belVita Blueberry • WHEAT THINS • NUTTER BUTTER • belVita Sandwich Peanut Butter • belVita Protein Oats, Honey & Chocolate The #1 peanut butter sandwich cookie1 America’s #1 #1 selling cookie The nation’s #1 breakfast biscuit1 is a top-10 winner chocolate chip cookie1 in America1 for breakthrough innovation in 20142 1. Nielsen, Market : xAOC plus Convenience. 52 weeks ending 8/26/17 2. Heller, Laura, “Nielsen’s Breakthrough Innovation Winners Turn Challenges into Sales” Forbes, May 6, 2014 2 Better-for-You Bites • Véa World Crisps • GOOD THiNS Sweet Potato • RITZ CRISP & THINS • OREO THINS Bites #1 selling cracker— filled & unfilled1 Delightful Dessert Inclusions • NUTTER BUTTER • CHIPS AHOY! • OREO Top branded ingredient on dessert menus3 Crème de la Candy America’s #1 sour confection brand is big among millennials 18–344 • SOUR PATCH KIDS • SOUR PATCH Watermelon • SWEDISH FISH Red • OREO Chocolate Candy Bar • OREO Chocolate Candy Bar Mint The nation’s #1 breakfast biscuit1 is a top-10 winner America’s #1 Cookie1 perfectly for breakthrough innovation in 20142 pairs with Europe’s #1 Chocolate1 3.
    [Show full text]
  • Innovation Is P&G's Life Blood
    Innovation is P&G Innovations P&G’s Life Blood It is the company’s core growth strategy and growth engine. It is also one of the company’s five core strengths, outlined for focus and investment. Innovation translates consumer desires into new products. P&G’s aim is to set the pace for innovation and the benchmark for innovation success in the industry. In 2008, P&G had five of the top 10 new product launches in the US, and 10 of the top 25, according to IRI Pacesetters, a report released by Information Resources, Inc., capturing the most successful new CPG products, as measured by sales, over the past year. Over the past 14 years, P&G has had 114 top 25 Pacesetters—more than our six largest competitors combined. PRODUCT INNOVATION FIRSTS 1879 IVORY First white soap equal in quality to imported castiles 1901 GILLETTE RAZOR First disposable razor, with a double-edge blade, offers alternative to the straight edge; Gillette joins P&G in 2005 1911 CRISCO First all-vegetable shortening 1933 DREFT First synthetic household detergent 1934 DRENE First detergent shampoo 1946 TIDE First heavy-duty The “washday miracle” is introduced laundry detergent with a new, superior cleaning formula. Tide makes laundry easier and less time-consuming. Its popularity with consumers makes Tide the country’s leading laundry product by 1949. 1955 CREST First toothpaste proven A breakthrough-product, using effective in the prevention fluoride to protect against tooth of tooth decay; and the first decay, the second most prevalent to be recognized effective disease at the time.
    [Show full text]
  • Approved Prenatal Medications Pain Medications • Tylenol
    Approved Prenatal Medications Pain Medications Tylenol (acetaminophen) for minor aches and pains, headaches. (Do not use: Aspirin, Motrin, Advil, Aleve, Ibuprofen.) Coughs/Colds Robitussin (Cough) Robitussin DM (non-productive cough) DO NOT USE TILL OVER 12 WEEKS Secrets and Vicks Throat Lozenges Mucinex Sore Throat Chloraseptic spray Saline Gargle Sucrets and Vicks Throat Lozenges Antihistamines/Allergies Zyrtec Claritin Benadryl Dimetapp Insomnia Benadryl Unison Hemorrhoids Preparation H Tucks Anusol Diarrhea Imodium (1-2 doses- if it persists please notify the office) BRAT diet (bananas, rice, applesauce, toast) Lice RID (only!) DO NOT USE Kwell Itching Benadryl Calamine or Caladryl Lotion Hydrocortisone cream Heartburn, Indigestion, Gas Tums Gas-X Mylanta Pepcid Maalox Zantac *DO NOT USE PEPTO BISMOL- it contains aspirin Decongestants Sudafed Robitussin CF- Only if over 12 weeks Tavist D Ocean Mist Nasal Spray (saline solutions) Nausea Small Frequent Meals Ginger Ale Vitamin B6 Sea Bands Yeast Infections Monistat Mycolog Gyne-lotrimin Toothache Orajel May see dentists, have cavity filled using Novocain or lidocaine, have x-rays with double lead shield, may have antibiotics in the Penicillin family (penicillin, amoxicillin) Sweetners- all should be consumed in moderation with water being consumed more frequently Nutrisweet (aspartame) Equal (aspartame) Splenda (sucralose) Sweet’n Low (saccharin) *note avoid aspartame if you have phenylketonuria (PKU) Constipation Colace Fibercon Citrucel Senokot Metamucil Milk of Magnesia Fiberall Miralax Eczema Hydrocortisone Cream Medications to AVOID Accurate Lithium Paxil Ciprofloxacin Tetracycline Coumadin Other Chemicals to AVOID Cigarettes Alcohol Recreational Drugs: marijuana, cocaine, ecstasy, heroin .
    [Show full text]
  • Johnson & Johnson Reports 2010 Second-Quarter Results
    Johnson & Johnson Reports 2010 Second-Quarter Results: Sales of $15.3 Billion Increased 0.6% Versus 2009 Second-Quarter; EPS was $1.23 Excluding Special Items, 2010 Second-Quarter EPS was $1.21, an increase of 5.2%* NEW BRUNSWICK, N.J., July 20, 2010 /PRNewswire via COMTEX News Network/ -- Johnson & Johnson (NYSE: JNJ) today announced sales of $15.3 billion for the second quarter of 2010, an increase of 0.6% as compared to the second quarter of 2009. Operational results increased 0.1% and the positive impact of currency was 0.5%. Domestic sales declined 2.8%, while international sales increased 4.1%, reflecting operational growth of 3.0% and a positive currency impact of 1.1%. Net earnings and diluted earnings per share for the second quarter of 2010 were $3.4 billion and $1.23, respectively. Second- quarter 2010 net earnings included an after-tax gain of $67 million representing the net impact of litigation matters. Excluding this special item, net earnings for the current quarter were $3.4 billion and diluted earnings per share were $1.21, representing increases of 5.4% and 5.2%, respectively, as compared to the same period in 2009.* The Company updated its earnings guidance for full-year 2010 to $4.65 - $4.75 per share, which excludes the impact of special items. The Company's guidance now reflects the impact of the voluntary recalls announced earlier this year of certain over-the-counter medicines and the suspension of manufacturing at the McNeil Consumer Healthcare facility in Fort Washington, Pa., as well as unfavorable changes in foreign currency exchange rates.
    [Show full text]
  • Sales of $20.7 Billion Reflecting Growth of 1.9%, Operational Growth of 3.2
    RESULTS HAVE BEEN UPDATED IN ACCORDANCE WITH THE FORM 8-K FILED ON OCTOBER 23, 2019 JOHNSON & JOHNSON REPORTS 2019 THIRD-QUARTER RESULTS: • Sales of $20.7 billion reflecting growth of 1.9%, operational growth of 3.2%* and adjusted operational growth of 5.2%* • EPS of $0.66 decreased (54.2)%; adjusted EPS of $2.12 increased 3.4%* • Company increasing Full Year Sales and EPS guidance due to strong performance New Brunswick, N.J. (October 23, 2019) – Johnson & Johnson (NYSE: JNJ) today announced results for third-quarter 2019. “Our third-quarter results represent strong performance, driven by competitive underlying growth in Pharmaceuticals and Medical Devices, as well as continued optimization in our Consumer business,” said Alex Gorsky, Chairman and Chief Executive Officer. “As we look ahead, we remain confident in the strength of our broad-based business model, which is fueled by our disciplined portfolio management, focus on transformational innovation and dedicated employees around the world who position us for success today and well into the future.” OVERALL FINANCIAL RESULTS: THIRD QUARTER ($ in Millions, except EPS) 2019 2018 % Change Reported Sales $ 20,729 $ 20,348 1.9% Net Earnings 1,753 3,934 (55.4) EPS (diluted) $ 0.66 $ 1.44 (54.2) Non-GAAP* THIRD QUARTER ($ in Millions, except EPS) 2019 2018 % Change Operational Sales1,2 3.2% Adjusted Operational Sales1,3 5.2 Adjusted Net Earnings1,4 5,672 5,590 1.5 Adjusted EPS (diluted)1,4 $ 2.12 $ 2.05 3.4 1 Non-GAAP financial measure; refer to reconciliations of non-GAAP financial measures
    [Show full text]